News

BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) today welcomes investors, analysts and financial media to the company's Capital Markets Day. The event, which starts at 10:30 CET, will be broadcast live ...
Founded in 1998 by Leonard A. and Ronald S. Lauder, the Alzheimer's Drug Discovery Foundation is dedicated to rapidly ...
Biogen will pay City Therapeutics $46m, which includes $16m upfront and $30m investment for a convertible note.
Biogen Inc. (NASDAQ: BIIB )’s recent partnership with City Therapeutics, Inc. to develop RNAi therapies for central nervous ...
In calling for more clinical testing of vaccines in younger people and those who face a low risk of severe disease from Covid ...
The FDA approved a test that can help clinicians diagnose Alzheimer's disease early on using a simple blood draw. The test ...
French pharma giant Sanofi SNY recently announced that it has agreed to acquire Massachusetts-based biotech Vigil ...
China continues to be a source of innovation as Pfizer strikes biggest pact yet; HHS provides more info on Trump’s Most ...
Marco Rubio testified before 2 Senate committees on Tuesday, while Health and Human Services Secretary Robert F. Kennedy Jr.
A dementia-focused transatlantic venture capital initiative has secured $269 million in commitments for its second fund. | A ...
The Food and Drug Administration has cleared the blood test to help diagnose Alzheimer's disease, potentially making it ...
Eisai has put direct-to-consumer (DTC) advertising at the heart of its ongoing efforts to expand demand for Leqembi. | Eisai ...